Graypoint LLC Boosts Stake in The Clorox Company (NYSE:CLX)

Graypoint LLC lifted its holdings in The Clorox Company (NYSE:CLX) by 9.5% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,269 shares of the company’s stock after buying an additional 370 shares during the period. Graypoint LLC’s holdings in Clorox were worth $693,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CLX. ST Germain D J Co. Inc. raised its position in Clorox by 7.5% in the fourth quarter. ST Germain D J Co. Inc. now owns 4,281 shares of the company’s stock worth $695,000 after acquiring an additional 300 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Clorox by 1.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 46,309 shares of the company’s stock worth $7,544,000 after purchasing an additional 532 shares during the period. Range Financial Group LLC lifted its stake in Clorox by 223.1% in the fourth quarter. Range Financial Group LLC now owns 4,972 shares of the company’s stock valued at $808,000 after purchasing an additional 3,433 shares during the last quarter. Canandaigua National Bank & Trust Co. grew its holdings in Clorox by 12.9% during the fourth quarter. Canandaigua National Bank & Trust Co. now owns 9,991 shares of the company’s stock valued at $1,623,000 after purchasing an additional 1,145 shares during the period. Finally, Central Pacific Bank Trust Division increased its position in Clorox by 40.2% in the fourth quarter. Central Pacific Bank Trust Division now owns 785 shares of the company’s stock worth $127,000 after buying an additional 225 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CLX. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and an average price target of $157.46.

Clorox Stock Down 1.9 %

Shares of NYSE CLX opened at $157.59 on Friday. The business has a 50-day moving average of $164.65 and a 200-day moving average of $155.71. The firm has a market capitalization of $19.51 billion, a price-to-earnings ratio of 54.91, a PEG ratio of 3.04 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company posted $0.49 EPS. The business’s quarterly revenue was up 27.0% on a year-over-year basis. Sell-side analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.10%. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.